Page last updated: 2024-09-03

n-benzyloxycarbonylprolylprolinal and vildagliptin

n-benzyloxycarbonylprolylprolinal has been researched along with vildagliptin in 1 studies

Compound Research Comparison

Studies
(n-benzyloxycarbonylprolylprolinal)
Trials
(n-benzyloxycarbonylprolylprolinal)
Recent Studies (post-2010)
(n-benzyloxycarbonylprolylprolinal)
Studies
(vildagliptin)
Trials
(vildagliptin)
Recent Studies (post-2010) (vildagliptin)
3907793186566

Protein Interaction Comparison

ProteinTaxonomyn-benzyloxycarbonylprolylprolinal (IC50)vildagliptin (IC50)
Dipeptidyl peptidase 9Bos taurus (cattle)0.68
Dipeptidyl peptidase IVPorphyromonas gingivalis1.3
Dipeptidyl peptidase 4Homo sapiens (human)0.1496
Dipeptidyl peptidase 4Mus musculus (house mouse)0.051
Prolyl endopeptidase FAPHomo sapiens (human)2.497
Dipeptidyl peptidase 8Homo sapiens (human)3.0627
Dipeptidyl peptidase 9Homo sapiens (human)0.4224
Dipeptidyl peptidase 2Homo sapiens (human)0.051

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Dufresne, C; Hédou, D; Labarre, A; Mittermaier, A; Moitessier, N; Plescia, J; Pousse, ME1

Other Studies

1 other study(ies) available for n-benzyloxycarbonylprolylprolinal and vildagliptin

ArticleYear
Modulating the selectivity of inhibitors for prolyl oligopeptidase inhibitors and fibroblast activation protein-α for different indications.
    European journal of medicinal chemistry, 2022, Oct-05, Volume: 240

    Topics: Endopeptidases; Enzyme Inhibitors; Humans; Membrane Proteins; Neoplasms; Prolyl Oligopeptidases; Serine Endopeptidases

2022